Overview
- 10 FDA inspections are on record.
- 3 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-09-25.
At a glance
Inspections
10
Form 483s
3
EIRs
0
Last outcome
Clean
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 24 Sep 2025 – 25 Sep 2025 | Human Drugs | Clean | |
| 9 Dec 2021 | Foods & Cosmetics | Clean | |
| 1 Dec 2021 – 8 Dec 2021 | Foods & Cosmetics | Clean | |
| 5 Jun 2017 | Foods & Cosmetics | Clean | |
| 24 Apr 2017 – 25 Apr 2017 | Foods & Cosmetics | Clean | |
| 11 Jan 2012 | Not recorded | 483 | View 483 → |
| 24 Nov 2010 | Not recorded | WL | View 483 → |
| 4 Aug 2009 | Not recorded | 483 | View 483 → |
| 19 May 2006 | Not recorded | Clean | |
| 29 Sep 2004 | Not recorded | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
11 Jan 2012
21 CFR 211.186(b)(9)
Complete instructions, procedures, specifications et. al.
Cited by Andrew J Lang
Investigators
FDA investigators tied to this site in the record.
Brittany M Kershaw2 insp.
Janet L Bowen2 insp.
Norman K Starks1 insp.
Edward R Kay1 insp.
Andrew J Barrowcliff1 insp.
Matthew B Casale1 insp.
Regina I Stoltzfus1 insp.
Andrew J Lang1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.100(b) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.125(a) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.186(b)(9) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.115(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.130(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.130(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.134(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.170(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.180(e)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.184(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.186(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188(b)(6) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188(b)(8) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.196 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.80(d) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Reese Pharmaceutical Company's 3 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat